Antibody Therapy Substitution - Immunomodulation - Monoclonal Immunotherapy /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Imbach, Paul (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
• Έκδοση: 1st ed. 2018.
• Θέματα: Hematology.; Immunology.; Oncology .; Oncology.

This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice). The book opens by tracing the transition from IgG subs...

Πίνακας περιεχομένων:

• The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation
• From ImmuneSubstitution to Immunomodulation
• Manual of Primary and Secondary Immunodeficiencies
• Manual of Intravenous and Subcutanous IgG Indications in Autoimmune diseases
• Anti-D IgG Concentrate; a Type of IVIg
• Mechanisms ofAction/Immunomodulation by IgG Concentrate
• Immunomodulatory Drugs and Monoclonal Antibodies
• Use of Intravenous Immunoglobulin in Neurology
• Use of Intravenous Immunoglobulin in Dermatology
• Historical Aspects ofPoliclonal IgG Preparations
• Basics of Immunoglobulins as Effector Molecules and Drugs
• Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates
• Current IgG Products and FuturePerspectives
• Immune Thrombocytopenia: Terminology, Immunomodulation and Platelet Stimulation, ClinicalGuidelines and Management
• Health-Related Quality of life in patients with Immune Thrombocytopenia
• ITP in Childhood: Predictors of Disease Duration
• Immune Functions of Platelets
• Thrombopoietin Receptor Agonists: Characteristics, Adverse Effects and Indications
• Registries in Immune Thrombocytopenia: The History of the Intercontinental Cooperative ITP Study Group
• Monoclonal Antibodies as Immunomodulators and Anti-CancerAgents : Development, Methods, Mechanisms of Actions, Adverse Effects, List of Registered and phase II/IIIMonoclonal Antibodies Targeted to
• Monoclonal Anti-CD20 (B-Cell) Antibody and Autoimmune Diseases.